Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2015 / Oct / A Tired Eye Tirade
Anterior Segment Cornea

A Tired Eye Tirade

Why is public awareness of dry eye so disturbingly low, and what can be done to change this?

By Mark Hillen 10/5/2015 1 min read

Share

Cast  your minds back to a time before you first studied eyes in earnest. If, like me, you’ve never needed spectacles or contact lenses, I’d like to ask: what brands, products and eye diseases were you aware of back then? If I remember correctly, the list for me was as follows: cataracts, AMD (thanks to my grandparents), contact lenses and solutions, something called LASIK for laser vision correction, and Optrex Eye Bath (thanks to the TV adverts in the 1980s).

I think the example of Optrex is thought-provoking. In the UK at least, it was a widely recognizable brand for “tired eyes” – and one that clearly made enough money to fund national TV ad campaigns, back in the day before people spent most of their days interacting with white LED-backlit computer, phone, tablet and TV screens blasting ~450 nm-wavelength blue light at them. I think for many of these people with “tired eyes”, what they actually had was some form of dry eye disease. So when walking through the exhibition hall at the recent ESCRS congress as an emmetrope with a professional (and personal) interest in dry eye, it was interesting to lament with laser manufacturers, refractive surgeons, pharma product managers and dry eye device manufacturers about the public awareness of the disease – specifically, the lack of it. Many people who have dry eye disease will suffer through ignorance; as a result, those with products to sell to treat it will sell fewer products, and surgeons offering a number of procedures like LASIK will either have to postpone surgery for treatment of their patients’ dry eye – or worse, never perform the procedure because of it. One thing was clear – everyone I spoke to would be happier if those with dry eye realized what they had, and did something about it. So if there’s a common interest across both industry and medicine to increase the awareness of dry eye, I have to ask: why don’t any Optrex-like TV advert campaigns for increasing awareness exist? Why aren’t there BuzzFeed articles informing internet-addicted teens and twentysomethings about the dry eye that undoubtedly affects (or will affect) many of them? Where are the sensational stories warning of the perils of dry eye in newspapers like the Daily Mail, Metro, Le Parisien or Bild? Stories about statins and stroke medicines seem to be popular in those particular tabloids. Why not dry eye? Politics, positioning and funding issues aside, a consistent approach from all stakeholders might produce an awareness amongst the public that should hopefully drive the right people to present to their pharmacist, optometrist, general practitioner, and when needed, their ophthalmologist. I believe that there’s a range of effective interventions out there – and I’d hope that eventually, all patients that need them, receive them.

About the Author(s)

Mark Hillen

I spent seven years as a medical writer, writing primary and review manuscripts, congress presentations and marketing materials for numerous – and mostly German – pharmaceutical companies. Prior to my adventures in medical communications, I was a Wellcome Trust PhD student at the University of Edinburgh.

More Articles by Mark Hillen

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: